Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 486 participants.

Also called NCT01121107

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 486 participants (enrolled count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01121107
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States, New Zealand (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01121107. Randomized; no masking; primary purpose diagnostic. Start 2010-04 (registry gives no type); primary completion 2015-04 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy
Acronym
LAPTOP-HF
Condition
Heart Failure
Intervention (Device)
Left Atrial Pressure Monitoring System
Intervention (Device)
Patient Advisory Module
Lead sponsor
Abbott Medical Devices (class: industry)

Record details

Record id
cardio:ct-nct01121107
Content hash
5c180a5ed139b1401b63cf55e45dcd8835df08a9500c4dca6c70b75217c2e697